Differential retinal angiogenic response to sustained intravitreal release of VEGF and bFGF in different pigmented rabbit breeds

Current Eye Research

Volumn 24, Issue 4, 2002, Pages 245-252

  Erb, M H ^a   Sioulis, C E ^a   Kuppermann, B D ^a   Osann, K ^a   Wong, Corinne G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal model; Basic fibroblast growth factor; Hemorrhage; Retinal angiogenic differences; Vascular endothelial growth factor

Indexed keywords

ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN; VISUAL PIGMENT;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREED; CONTROLLED STUDY; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; GENETICS; IMPLANTATION; MALE; NONHUMAN; OPTIC DISK; PHOTOGRAPHY; PRIORITY JOURNAL; RABBIT; RETINA; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA NEOVASCULARIZATION; STATISTICAL ANALYSIS;

ANIMALS; DRUG COMBINATIONS; DRUG IMPLANTS; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; RABBITS; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; SPECIES SPECIFICITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036394551     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.24.4.245.8412     Document Type: Article

References (41)

1. Tasmon W, Brown GC, Schaffer DB, Quinn G, Naidoff M, Benson BE, Diamond G. Cryotherapy for active retinopathy of prematurity. Ophthalmology. 1986;93:580-585.
2. D'Amore PA. Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci. 1994;35:3974-3979.
3. Votruba M, Gregor Z. Neovascular age-related macular degeneration: Present and future treatment options. Eye. 2001;15:424-429.
4. Kahn H, Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol. 1974;78:58-67.
5. Musarella MA. Molecular genetics of macular degeneration. Doc Ophthalmol. 2001;102:165-177.
6. Pieramici DJ, Bressler SB. Age-related macular degeneration and risk factors for the development of choroidal neovascularization in the fellow eye. Curr Opin Ophthalmol. 1998;9:38-46.
7. Campochiaro PA, Soloway P, Ryan SJ, Miller JW. The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration. Mol Vis. 1999;5:34-35.
8. Avivi A, Skorecki K, Yayon A, Givol D. Promoter region of the murine fibroblast growth factor receptor 2 (bek/KGFR) gene. Oncogene. 1992;10:1957-1962.
9. Wong CG, Rich KA, Liaw LHL, Hsu HT, Berns MW. Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit. Curr Eye Res. 2001;22:140-147.
10. Ozaki H, Hayashi H, Vinores SA, Moromizato Y, Campochiaro PA, Oshima, K. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res. 1997;64:505-517.
11. Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K, Ferrara N, Adamis AP. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology. 1996;103:1820-1828.
12. Aiello L, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen H, Ferrara N, King G. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Eng J Med. 1994;331:1480-1487.
13. Mandarino LJ. Current hypotheses for the biochemical basis of diabetic retinopathy. Diabetes Care. 1992;15:1892-1901.
14. Ryan SJ. Traction retinal detachment. XLIX Edward Jackson Memorial Lecture. Am J Ophthalmol. 1993;115:1-20.
15. Adamis AP, Miller JW, Bernal MT, D'Amico DJ, Folkman J, Yeo TK, Yeo KT. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118:445-450.
16. Chakrabarti S, Cukiernik M, Hileeto D, Evans T, Chen S. Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy. Diabetes Metab Res Rev. 2000;16:393-407.
17. Aiello KP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int Suppl. 2000;77:S113-S119.
18. Chen Z, Milner TE, Wang X, Srinivas S, Nelson JS. Optical doppler tomography: Imaging in vivo blood flow dynamics following pharmacological intervention and photodynamic therapy. Photochem Photobiol. 1998;67:1-7.
19. Massin P, Vicaut E, Haouchine B, Erginay A, Paques M, Gaudric A. Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol. 2001;119:1135-1142.
20. Lobo C, Bernardes R, Faria de Abreu JR, Cunha-Vaz JG. Novel imaging techniques for diabetic macular edema. Doc Ophthalmol. 1999;97:341-347.
21. Lang I, Hoffmann C, Olip H, Pabst MA, Hahn T, Dohr G, Desoye G. Differential mitogenic responses of human macrovascular and microvascular endothelial cells to cytokines underline their phenotypic heterogeneity. Cell Prolif. 2001;34:143-155.
22. LeCouter J, Kowalski J, Foster J, Hass Ph, Zhang Z, Dillard-Telms L, Frantz G, Rangell L, DeGuzman L, Keller GA, Peales F, Gurney A, Hillan KJ, Ferrara N. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature. 2001;412:877-884.
23. Rohan RM, Fernandez A, Udagawa T, Yuan J, D'Amato RJ. Genetic heterogeneity of angiogenesis in mice. FASEB J. 2000;14:871-876.
24. Stewart LL, Field LL, Ross S, McArthur RG. Genetic risk factors in diabetic retinopathy. Diabetologia. 1993;6:1293-1298.
25. Agardh D, Gaur LK, Agardh E, Landin-Olsson M, Agardh CD, Lernmark A. HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM. Diabetologia. 1996;39:1313-1317.
26. Wong TY, Cruickshank KJ, Klein R, Klein BE, Moss SE, Palta M, Riley WJ, Maclaren NK, Vadheim CM, Rotter JI. HLA-DR3 and DR4 and their relation to the incidence and progression of diabetic retinopathy. Ophthalmology. 2002;109:275-281.
27. Gregor Z, Joffe I. Senile macular changes in the black African. Br J Ophthalmol. 1978;62:547.
28. Wong C, Wilson M, Berns MW. Bioengineering retinal blood vessels with pro-angiogenic polymeric scaffolds. ARVO. 2002; Fort Lauderdale, FL.
29. Friedrich S, Cheng YL, Saville B. Drug distribution in the vitreous humor of the human eye: The effects of intravitreal injection position and volume. Curr Eye Res. 1997;16:663-669.
30. Friedrich S, Cheng YL, Saville B. Finite element modeling of drug distribution in the vitreous humor of the rabbit eye. Ann Biomed Eng. 1997;25:303-314.
31. Grisanti S, Esser P, Schraermeyer U. Retinal pigment epithelial cells: Autocrine and paracrine stimulation of extracellular matrix contraction. Graefes Arch Clin Exp Ophthalmol. 1997;235:587-598.
32. Glaser BM, Cardin A, Biscoe B. Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction. Ophthalmology. 1987;94:327-332.
33. Boulton M, Dayhaw-Barker P. The role of the retinal pigment epithelium: Topographical variation and ageing changes. Eye. 2001;15:384-389.
34. Choudhury P, Chen W, Hunt RC. Production of platelet-derived growth factor by interleukin-1 beta and transforming growth factor-beta-stimulated retinal pigment epithelial cells leads to contraction of collagen gels. Invest Ophthalmol Vis Sci. 1997;38:824-833.
35. Hiscott P, Gray R, Grierson I, Gregor Z. Cytokeratin-containing cells in proliferative diabetic retinopathy membranes. Br J Ophthalmol. 1994;78:219-222.
36. Yang CH, Huang TF, Liu KR, Chen MS, Hung PT. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom. Invest Ophthalmol Vis Sci. 1996;37:843-854.
37. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu JH, Benedict W, Bouck NP. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science. 1999;285:245-248.
38. Mori K, Duh E, Gehlbach P, Ando A, Takahasi K, Pearlman J, Mori K, Yang HS, Zack DJ, Ettyreddy D, Brough DE, Wei LL, Campochiaro PA. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. Cell Physiol. 2001;188:253-263.
39. D'Amore PA. Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci. 1994;35:3974-3979.
40. Verma D. Pathogenesis of diabetic retinopathy: The missing link? Med Hypotheses. 1993;41:205-210.
41. Kristinsson JK, Gottfredsdottir MS, Stefansson E. Retinal vessel dilatation and elongation precedes diabetic macular edema. Br J Ophthalmol. 1997;81:274-278.